Literature DB >> 23152401

Multiple sclerosis and glutamate excitotoxicity.

Milos Kostic1, Nikola Zivkovic, Ivana Stojanovic.   

Abstract

The previous understanding of multiple sclerosis was solely related to neuroinflammation and its harmful effects; however, countless data indicate the importance of some inflammation-independent, neurodegenerative mechanisms associated with mitochondria malfunction, iron deposition and oxidative stress. Recently, it has been postulated that glutamate excitotoxicity, a phenomenon that takes place when an excessive amount of glutamate overactivates its cellular receptors and induces cell death, could be a missing link between inflammatory and neurodegenerative processes evident in multiple sclerosis. Glutamate is the major excitatory neurotransmitter of the central nervous system, which has been proven to have a central role in a complex communication network established between all residential brain cells, including neurons, astrocytes, oligodendrocytes and microglia. Thus, the disturbance of glutamate homeostasis could affect practically all physiological functions and interactions of brain cells, leading to heterogeneity of pathological events. The understanding of glutamate excitotoxicity as a valid mechanism of central nervous system damage in multiple sclerosis, requires the revision of the current knowledge about a source of elevated extracellular glutamate, glutamate receptor alterations, alterations of glutamate transporters and metabolizing enzymes, as well as molecular mechanism of excitotoxic damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23152401     DOI: 10.1515/revneuro-2012-0062

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  36 in total

1.  pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.

Authors:  David Kremer; Joel Gruchot; Vivien Weyers; Lisa Oldemeier; Peter Göttle; Luke Healy; Jeong Ho Jang; Yu Kang T Xu; Christina Volsko; Ranjan Dutta; Bruce D Trapp; Hervé Perron; Hans-Peter Hartung; Patrick Küry
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

Review 2.  A Precision Medicine Approach to Cerebral Edema and Intracranial Hypertension after Severe Traumatic Brain Injury: Quo Vadis?

Authors:  Ruchira M Jha; Patrick M Kochanek
Journal:  Curr Neurol Neurosci Rep       Date:  2018-11-07       Impact factor: 5.081

Review 3.  Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Authors:  Hong Shi; Xiaoming Hu; Rehana K Leak; Yejie Shi; Chengrui An; Jun Suenaga; Jun Chen; Yanqin Gao
Journal:  Exp Neurol       Date:  2015-03-24       Impact factor: 5.330

4.  Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study.

Authors:  Prejaas Tewarie; Menno M Schoonheim; Daphne I Schouten; Chris H Polman; Lisanne J Balk; Bernard M J Uitdehaag; Jeroen J G Geurts; Arjan Hillebrand; Frederik Barkhof; Cornelis J Stam
Journal:  Hum Brain Mapp       Date:  2014-10-08       Impact factor: 5.038

5.  JHU-083 selectively blocks glutaminase activity in brain CD11b+ cells and prevents depression-associated behaviors induced by chronic social defeat stress.

Authors:  Xiaolei Zhu; Michael T Nedelcovych; Ajit G Thomas; Yuto Hasegawa; Aisa Moreno-Megui; Wade Coomer; Varun Vohra; Atsushi Saito; Gabriel Perez; Ying Wu; Jesse Alt; Eva Prchalova; Lukáš Tenora; Pavel Majer; Rana Rais; Camilo Rojas; Barbara S Slusher; Atsushi Kamiya
Journal:  Neuropsychopharmacology       Date:  2018-08-13       Impact factor: 7.853

Review 6.  The CNS under pathophysiologic attack--examining the role of K₂p channels.

Authors:  Petra Ehling; Manuela Cerina; Thomas Budde; Sven G Meuth; Stefan Bittner
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

Review 7.  Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases.

Authors:  Egle Cekanaviciute; Marion S Buckwalter
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 8.  Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.

Authors:  Lei Yang; Dewei Tan; Hua Piao
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

9.  β1-Integrin- and KV1.3 channel-dependent signaling stimulates glutamate release from Th17 cells.

Authors:  Katharina Birkner; Beatrice Wasser; Tobias Ruck; Carine Thalman; Dirk Luchtman; Katrin Pape; Samantha Schmaul; Lynn Bitar; Eva-Maria Krämer-Albers; Albrecht Stroh; Sven G Meuth; Frauke Zipp; Stefan Bittner
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

10.  AMPA-Kainate Receptor Inhibition Promotes Neurologic Recovery in Premature Rabbits with Intraventricular Hemorrhage.

Authors:  Preeti Dohare; Muhammad T Zia; Ehsan Ahmed; Asad Ahmed; Vivek Yadala; Alexandra L Schober; Juan Alberto Ortega; Robert Kayton; Zoltan Ungvari; Alexander A Mongin; Praveen Ballabh
Journal:  J Neurosci       Date:  2016-03-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.